Genome editing in pigs has tremendous practical applications for biomedicine. The advent of genome editing technology, with its use of site-specific nucleases-including ZFNs, TALENs, and the CRISPR/Cas9 system-has popularized targeted zygote genome editing via one-step microinjection in several mammalian species. Here, we review methods to optimize the developmental competence of genome-edited porcine embryos and strategies to improve the zygote genome-editing efficiency in pigs.
K E Y W O R D SCRISPR/Cas9, cytoplasmic microinjection, in vitro-produced zygotes, in vivo-derived zygotes,
TALEN, ZFNOne-step production of genetically modified pigs . . . is simple and efficient, and holds the potential to be a powerful tool for genome manipulation for biomedical and biotechnological applications.